A Systematic Review on the Readmission of COVID-19 Patient: Frequency and Individual Factors
Kriswiharsi Kun Saptorini, Tiara Fani, Slamet Isworo
Asian Journal of Medicine and Health · pp. 1–16 · Published 13 Apr 2023
10.9734/ajmah/2023/v21i7823Abstract
Background and Objectives: The COVID-19 pandemic has severely damaged the world economy. Due to the COVID-19 infection, hospitalization is in high demand. Numerous COVID-19 patients are treated medically, released from the hospital, and then relapse and need to undergo treatment because they test positive. This places a strain on the health services, and the number of relapses is rarely reported in the literature. The purpose of the study is to assess individual and frequency-based factors that influence readmission of COVID-19 patients. Methods: This study uses a systematic review of the literature, using the PICO strategy for the construction of the research question, the bibliographic search and the best available scientific information in the systematization. Results: The traits of the chosen studies are compiled in Table 3. In the period from March 30, 2020, to February 23, 2021, 28 studies were published. The majority of studies were carried out in China, with Wuhan reporting the highest number. There were also some studies conducted outside of China, including one from South Korea, six from the United States specifically, one from Spain, and one from Turkey. Age 65 was a risk factor for readmission or re-positive rates, which ranged from 3.6% to 67.1%. Conclusion: The hospital strictly controls Covid-19 patients before they are allowed to leave the hospital to prevent recurrence as a result of relapse in Covid-19 patients during the pandemic.
References (28)
- 1 Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China [DOI]
- 2 Cochrane Handbook for Systematic Reviews of Interventions [DOI]
- 3 Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data [DOI]
- 4 What kind of systematic review should I conduct? A proposed typology and guidance for systematic reviewers in the medical and health sciences [DOI]
- 5 Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7) [DOI]
- 6 Clinical, immunological and virological characterization of COVID-19 patients that test re-positive for SARS-CoV-2 by RT-PCR [DOI]
- 7 Recurrence of positive SARS-CoV-2 viral RNA in recovered COVID-19 patients during medical isolation observation [DOI]
- 8 Characterization of Patients Who Return to Hospital Following Discharge from Hospitalization for COVID-19 [DOI]
- 9 Readmissions among patients with COVID‐19 [DOI]
- 10 Hospital Readmissions of Discharged Patients with COVID-19 [DOI]
- 11 Recurrent Positive Reverse Transcriptase–Polymerase Chain Reaction Results for Coronavirus Disease 2019 in Patients Discharged From a Hospital in China [DOI]
- 12 Assessment of thirty‐day readmission rate, timing, causes and predictors after hospitalization with COVID‐19 [DOI]
- 13 Analysis of Risk Factors on Readmission Cases of COVID-19 in the Republic of Korea: Using Nationwide Health Claims Data [DOI]
- 14 Incidence, clinical course and risk factor for recurrent PCR positivity in discharged COVID-19 patients in Guangzhou, China: A prospective cohort study [DOI]
- 15 Thirty-day readmission rate of COVID-19 patients discharged from a tertiary care university hospital in Turkey: an observational, single-center study [DOI]
- 16 Clinical course and risk factors for recurrence of positive SARS-CoV-2 RNA: a retrospective cohort study from Wuhan, China [DOI]
- 17 The treatment and follow‐up of ‘recurrence’ with discharged COVID ‐19 patients: data from Guizhou, China [DOI]
- 18 Hospital Readmissions After Implementation of a Discharge Care Program for Patients with COVID-19 Illness [DOI]
- 19 Clinical characteristics of rehospitalized patients with COVID‐19 in China [DOI]
- 20 Clinical and Laboratory Findings in Patients With Potential Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection, May–July 2020 [DOI]
- 21 Epidemiological and Clinical Findings of Short-Term Recurrence of Severe Acute Respiratory Syndrome Coronavirus 2 Ribonucleic Acid Polymerase Chain Reaction Positivity in 1282 Discharged Coronavirus Disease 2019 Cases: A Multicenter, Retrospective, Observational Study [DOI]
- 22 Reactivation of SARS-CoV-2 infection following recovery from COVID-19 [DOI]
- 23 World Health Organization [DOI]
- 24 Twelve out of 117 recovered COVID-19 patients retest positive in a single-center study of China [DOI]
- 25 Prevalence and impact factors of recurrent positive SARS-CoV-2 detection in 599 hospitalized COVID-19 patients [DOI]
- 26 Clinical characteristics and potential factors for recurrence of positive SARS-CoV-2 RNA in convalescent patients: a retrospective cohort study [DOI]
- 27 Viral RNA level, serum antibody responses, and transmission risk in discharged COVID-19 patients with recurrent positive SARS-CoV-2 RNA test results: a population-based observational cohort study [DOI]
- 28 COVID-19 Recurrent Varies with Different Combinatorial Medical Treatments Determined by Machine Learning Approaches [DOI]
Cited by 0
No indexed citations yet.
Article metrics
Real usage data collected on this platform.
12
Page views
0
PDF downloads
2
Outbound clicks
0
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.